Stockscreener 앱 받기
1.215
4.74%
0.055
시간 외 거래:
1.21
-0.005
-0.41%
전일 마감가:
$1.16
열려 있는:
$1.13
하루 거래량:
687.38K
Relative Volume:
0.84
시가총액:
$89.41M
수익:
$311.14M
순이익/손실:
$-177.97M
주가수익비율:
-0.4797
EPS:
-2.5329
순현금흐름:
$-20.82M
1주 성능:
-32.12%
1개월 성능:
-34.68%
6개월 성능:
-57.96%
1년 성능:
-73.06%
1일 변동 폭
$1.13
$1.2799
1주일 범위
$1.04
$1.4794
52주 변동 폭
$1.04
$5.062
Health Catalyst Inc Stock (HCAT) Company Profile
명칭
Health Catalyst Inc
전화
801-708-6800
주소
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, TEM, BTSG, HQY, MMED
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
1.215 | 85.36M | 311.14M | -177.97M | -20.82M | -2.5329 |
|
VEEV
Veeva Systems Inc
|
185.59 | 30.25B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
48.74 | 8.70B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.99 | 8.27B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
81.13 | 6.80B | 1.29B | 191.83M | 362.67M | 2.182 |
|
MMED
Minimed Group Inc
|
17.11 | 4.71B | 0 | 0 | 0 | 0.00 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-08-27 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-08-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-01-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2024-01-03 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-11-13 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-05-10 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-04-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-10-31 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-25 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-05 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-03-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-10-14 | 개시 | BTIG Research | Buy |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2020-12-08 | 개시 | Berenberg | Buy |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-06-18 | 개시 | Stifel | Buy |
| 2020-06-15 | 재개 | Evercore ISI | Outperform |
| 2020-05-15 | 개시 | Guggenheim | Buy |
| 2020-04-21 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-04-02 | 개시 | Canaccord Genuity | Buy |
| 2019-12-20 | 개시 | Raymond James | Strong Buy |
| 2019-10-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-08-19 | 개시 | Evercore ISI | Outperform |
| 2019-08-19 | 개시 | Goldman | Buy |
| 2019-08-19 | 개시 | JP Morgan | Overweight |
| 2019-08-19 | 개시 | Piper Jaffray | Overweight |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
| 2019-08-19 | 개시 | SunTrust | Buy |
| 2019-08-19 | 개시 | William Blair | Outperform |
모두보기
Health Catalyst Inc 주식(HCAT)의 최신 뉴스
Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2025 Earnings Call Transcript - Insider Monkey
Health Catalyst (HCAT) Stock Trades Down, Here Is Why - Yahoo Finance
Wells Fargo Adjusts Outlook for Health Catalyst (HCAT) - GuruFocus
Health Catalyst stock downgraded at Wells Fargo (HCAT:NASDAQ) - Seeking Alpha
Total debt per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Health Catalyst down as Piper Sandler adds to downgrades on Q2 results - MSN
HCAT Downgraded: Wells Fargo Lowers Price Target by 80% | HCAT S - GuruFocus
Health Catalyst (NASDAQ:HCAT) Earns Equal Weight Rating from Wells Fargo & Company - MarketBeat
Wells Fargo Downgrades Health Catalyst to Equalweight From Overweight, Adjusts PT to $1 From $5 - marketscreener.com
Wells Fargo downgrades Health Catalyst stock rating on structural concerns - Investing.com
Health Catalyst Q4 2025 Earnings: Revenue Exceeds Forecasts, Margins DeclineNews and Statistics - IndexBox
HCAT Q4 Deep Dive: Margin Focus and Strategic Review Amid Platform Migration Pressures - TradingView
Health Catalyst 2025 Results & 2026 Outlook: Ignite Platform & Growth StrategyNews and Statistics - IndexBox
Health Catalyst (HCAT) Q4 2025 Earnings Transcript - AOL.com
Market Recap: Is Health Catalyst Inc a top pick in the sector2026 Retail & Reliable Trade Execution Plans - baoquankhu1.vn
Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Up 18.1% in February - MarketBeat
Health Catalyst Sees Increased Investment from First Light Asset Management - National Today
Health Catalyst, Inc. $HCAT is First Light Asset Management LLC's 7th Largest Position - MarketBeat
Health Catalyst, Inc. (NASDAQ:HCAT) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Net current asset value per share of Health Catalyst, Inc. – FWB:2YP - TradingView
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION) and Health Catalyst (HCAT) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT) - The Globe and Mail
Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative - simplywall.st
HCAT Rating Maintained as Citigroup Lowers Price Target | HCAT S - GuruFocus
Citigroup Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $1.75 - MarketBeat
Health Catalyst, IncCommon stock (NQ: HCAT - The Chronicle-Journal
Health Catalyst (HCAT) Shares Plummet After Mixed Q4 Results - GuruFocus
Health Catalyst (HCAT) Receives Analyst Rating Update from Steph - GuruFocus
HCAT: Canaccord Genuity Lowers Price Target But Maintains Buy Ra - GuruFocus
Health Catalyst (NASDAQ:HCAT) Given New $2.00 Price Target at Stephens - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Health Catalyst plummets after mixed Q4; CEO declines to rule out potential sale as part of review - Seeking Alpha
Stifel Nicolaus Lowers Health Catalyst (NASDAQ:HCAT) Price Target to $2.00 - MarketBeat
Canaccord cuts Health Catalyst stock price target on weak guidance - Investing.com Nigeria
Canaccord cuts Health Catalyst stock price target on weak guidance By Investing.com - Investing.com South Africa
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com Nigeria
Health Catalyst, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cantor Fitzgerald cuts Health Catalyst stock price target on turnaround uncertainty - Investing.com
Stifel cuts Health Catalyst stock price target on migration woes By Investing.com - Investing.com Australia
Health Catalyst (HCAT) CEO executes mandated sell-to-cover tax transaction - Stock Titan
Health Catalyst Q4 2025 Financial Report: Revenue $74.7M, Loss $91MNews and Statistics - IndexBox
Health Catalyst Q4 2025 earnings preview - MSN
First Light details 18.3% Health Catalyst (HCAT) stake in amended 13D - Stock Titan
Earnings call transcript: Health Catalyst Q4 2025 results show mixed performance - Investing.com Nigeria
Health Catalyst refrains from 2026 annual guidance as new CEO launches operational overhaul and strategic review - MSN
Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Earnings Call Summary | Health Catalyst(HCAT.US) Q4 2025 Earnings Conference - 富途牛牛
Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Nav - GuruFocus
Health Catalyst (HCAT) Reports $311.1M Revenue for 2025, New Lea - GuruFocus
Health Catalyst Q4 Earnings Call Highlights - MarketBeat
Health Catalyst Inc (HCAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
자본화:
|
볼륨(24시간):